These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18279620)

  • 1. [Expression and significance of E-cadherin, CD44v6, and proliferating cell nuclear antigen in non-small cell lung cancer].
    Weng MX; Wu CH; Yang XP
    Ai Zheng; 2008 Feb; 27(2):191-5. PubMed ID: 18279620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of ezrin in human non-small cell lung cancer and its relationship with metastasis and prognosis].
    Chen QY; Yan J; Hu HZ; Chen FY; Song J; Jiang ZY; Jiao DM; Wu YQ
    Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):436-40. PubMed ID: 22967445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of nucleostemin and proliferating cell nuclear antigen protein expression in non-small cell lung cancer.
    Li X; Liu X; Cui D; Wu X; Qian R
    J BUON; 2015; 20(4):1088-93. PubMed ID: 26416061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of proliferating cell nuclear antigen and CD44 variant isoforms in the primary and metastatic sites of nonsmall cell lung carcinoma with intrapulmonary metastases.
    Fukuse T; Hirata T; Naiki H; Hitomi S; Wada H
    Cancer; 1999 Oct; 86(7):1174-81. PubMed ID: 10506701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor.
    Hirata T; Fukuse T; Naiki H; Hitomi S; Wada H
    Cancer Res; 1998 Mar; 58(6):1108-10. PubMed ID: 9515789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The expression of vascular endothelial growth factor, CD44v6 in non-small cell lung carcinoma].
    Mei TH; Zhang GR; Ma Y
    Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):647-50. PubMed ID: 15329250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic significance of E-cadherin and Ki-67 expression in non-small cell lung cancer patients.
    He LY; Zhang H; Wang ZK; Zhang HZ
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3812-3817. PubMed ID: 27735037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of standard and variant CD44 in human lung cancer].
    Zhao H; Fang J; Du G
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):541-3. PubMed ID: 11360506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
    Tang XJ; Zhou QH; Zhang SF; Liu LX
    Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of proliferative activity in pN2 non-small-cell lung carcinomas and their mediastinal lymph node metastases.
    Fukuse T; Hirata T; Naiki H; Hitomi S; Wada H
    Ann Surg; 2000 Jul; 232(1):112-8. PubMed ID: 10862203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of expression of proliferating cell nuclear antigen and E-cadherin in gastric carcinoma.
    Hu L; Li HL; Li WF; Chen JM; Yang JT; Gu JJ; Xin L
    World J Gastroenterol; 2017 May; 23(20):3721-3729. PubMed ID: 28611525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of high expression of proliferating cell nuclear antigen in non-small cell lung cancer.
    Ye X; Ling B; Xu H; Li G; Zhao X; Xu J; Liu J; Liu L
    Medicine (Baltimore); 2020 Apr; 99(16):e19755. PubMed ID: 32311975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.
    Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y
    Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cadherin expression in surgically-resected non-small cell lung cancers--a clinicopathological study.
    Lee YC; Wu CT; Chen CS; Chang YL
    Thorac Cardiovasc Surg; 2000 Oct; 48(5):294-9. PubMed ID: 11100763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of CD44 variant exon 6 expression in non-small cell lung cancer: a meta-analysis.
    Zhao S; He JL; Qiu ZX; Chen NY; Luo Z; Chen BJ; Li WM
    Asian Pac J Cancer Prev; 2014; 15(16):6761-6. PubMed ID: 25169522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship of the expression of CD44v6 and paxillin to the prognosis of non-small cell lung carcinoma].
    Zuo W; Li H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):484-5. PubMed ID: 12910696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inverse correlation of S100A4 and E-cad protein expression and their clinical significance in non-small cell lung cancer].
    Qi RX; Xu XY
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):681-4. PubMed ID: 18246798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.